FeesSafety
Pluang+

Lisata Therapeutics appoints Jeff Farrow to Board, boosting financial expertise amid clinical advances.

Market News
14 Oct 2026, 23:05 WIB
GlobeNewsWire
View Source
Bullish
Lisata Therapeutics appoints Jeff Farrow to Board, boosting financial expertise amid clinical advances.

Lisata Therapeutics has appointed Jeffrey Farrow to its Board of Directors, expanding the board to eight members. Farrow, a veteran biopharma CFO with over 15 years of public company experience, will join the Audit Committee. His expertise is expected to support Lisata's ongoing Phase 2b clinical programs for severe hypertriglyceridemia and acromegaly. This strategic move aims to strengthen the company's financial leadership as it advances its drug development pipeline.

Lisata Therapeutics' board expansion with Jeffrey Farrow provides context for readers interested in biopharma leadership changes. For readers following the Health sector, here is Pluang's market snapshot as of Oct 15, 2026 03:02 WIB: Out of 150 priced Health-sector US stocks, 90 rose and 60 fell today. Among notable movers, MiniMed Group Inc. (MMED) declined 9.18% to USD 16.71 with a typical hold time of 6 days, Alumis Inc. (ALMS) dropped 7.39% to USD 6.08 with a typical hold time of 0 days and 100% buy order activity, while Heron Therapeutics Inc. (HRTX) fell 6.89% to USD 0.36 with a typical hold time of 36 days and 67% buy order activity.

More News

A Race Against Blindness relaunches holiday fundraiser with $125K family prize package including Toyota Sienna and Disney vacation

A Race Against Blindness relaunches holiday fundraiser with $125K family prize package including Toyota Sienna and Disney vacation

A Race Against Blindness has brought back its popular Miles, Magic & Mochas holiday fundraiser, offering supporters a chance to win a prize package valued at $125,000. The package includes a 2026 Toyota Sienna Platinum, a $20,000 Disney vacation awar...

Neutral
19 minutes ago
Shell buys back over 2 million shares as part of its ongoing repurchase program.

Shell buys back over 2 million shares as part of its ongoing repurchase program.

On November 18, 2026, Shell plc repurchased a total of approximately 2.15 million shares across multiple trading venues including the London Stock Exchange and European markets. These shares are being bought back for cancellation under Shell's existi...

Company Fundamentals
Neutral
25 minutes ago
MercadoLibre and Amazon show strong long-term growth despite short-term profit challenges.

MercadoLibre and Amazon show strong long-term growth despite short-term profit challenges.

MercadoLibre and Amazon have both delivered impressive returns over the past decade by continuously growing their customer base, revenue, and profits. MercadoLibre is deliberately sacrificing short-term profits to invest in long-term growth, expandin...

Market News
Bullish
34 minutes ago
Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite potential challenges ahead.

Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite potential challenges ahead.

Pfizer will pay its 352nd consecutive quarterly dividend on December 7, 2026, maintaining a strong track record for investors. The company faces challenges like a patent cliff, costly acquisitions, and clinical setbacks that could threaten this strea...

Company Fundamentals
Neutral
35 minutes ago
General Mills and Realty Income offer high dividend yields as their stock prices near 52-week lows.

General Mills and Realty Income offer high dividend yields as their stock prices near 52-week lows.

General Mills and Realty Income are trading near their 52-week lows, presenting attractive dividend yields of about 7% and 5.7% respectively. General Mills has a strong dividend history of 127 years and covers its dividend with free cash flow despite...

Market News
Bullish
44 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App